Related references
Note: Only part of the references are listed.Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
Jessica M. Conway et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
Kim Anthony-Gonda et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Nonlinear Mixed-Effects Modeling Programs in R
Gabriela Stegmann et al.
STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL (2018)
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Erica N. Borducchi et al.
NATURE (2018)
The need for treatment interruption studies and biomarker identification in the search for an HIV cure
Jonathan Z. Li et al.
AIDS (2015)
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption
Meghan K. Rothenberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst et al.
NATURE COMMUNICATIONS (2015)
Posttreatment controllers: what do they tell us?
Christine Rouzioux et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation Report of 2 Cases
Timothy J. Henrich et al.
ANNALS OF INTERNAL MEDICINE (2014)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
On fitting generalized linear mixed-effects models for binary responses using different statistical packages
Hui Zhang et al.
STATISTICS IN MEDICINE (2011)
AIDS Clinical Trials Group 5197: A Placebo-Controlled Trial of Immunization of HIV-1-Infected Persons with a Replication-Deficient Adenovirus Type 5 Vaccine Expressing the HIV-1 Core Protein
Robert T. Schooley et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection
Eric S. Rosenberg et al.
PLOS ONE (2010)
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment
Paul Volberding et al.
AIDS (2009)
Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial
Marie-Anne Bouldouyre et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Fast Implementation for Normal Mixed Effects Models With Censored Response
Florin Vaida et al.
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024)
J. Michael Kilby et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model:: Application to HIV dynamics model
Adeline Samson et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2006)
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP 1452, promotes host control of HIV replication: The results of AIDS Clinical Trials Group 5068
Jeffrey M. Jacobson et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Structured treatment interruptions in primary HIV-1 infection - The ANRS 100 PRIMSTOP Trial
B Hoen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Maximum likelihood estimation in nonlinear mixed effects models
E Kuhn et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2005)
Simple fitting of subject-specific curves for longitudinal data
M Durbán et al.
STATISTICS IN MEDICINE (2005)
Exact and approximate inferences for nonlinear mixed-effects models with missing covariates
L Wu
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection
CL Tremblay et al.
AIDS (2003)
A joint model for nonlinear mixed-effects models with censoring and covariates measured with error, with application to AIDS studies
L Wu
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)
Modelling HIV viral rebound using non-linear mixed effects models
AP Fitzgerald et al.
STATISTICS IN MEDICINE (2002)
Warning: Antiretroviral treatment interruption could lead to an increased risk of HIV transmission
R Tubiana et al.
AIDS (2002)
Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection
R Colven et al.
ANNALS OF INTERNAL MEDICINE (2000)
The stochastic EM algorithm: Estimation and asymptotic results
SF Nielsen
BERNOULLI (2000)
Share Paper
